Climb Bio, Inc. (CLYM)
Latest CLYM Insider Trades
About Climb Bio, Inc. (CLYM)
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
- WELLESLEY HILLS, MA
- 29
- 2021
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 30,902 | $407K |
| Grant or award | 9 | 420,568 | |
| Option exercise | 2 | 137,500 |
CLYM Insider Transactions (Form 4)
3626 Form 4 filings on record, the earliest from Nov 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Stock Option (Right to Buy) | 70,284 |
Recent CLYM Form 8-K Filings
5Recent CLYM Form 144 Notices of Proposed Sale
1A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
CLYM Insider Trading - FAQ
What is the latest insider trade for CLYM?
Climb Bio, Inc. (CLYM) had 10 insider filings in the last 90 days, with the most recent on 2026-07-01. The full record for CLYM runs to 26 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CLYM stock?
No insider purchases of CLYM were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling CLYM stock?
1 insider sale of CLYM was filed in the last 90 days, totaling $407K.
Where can I see CLYM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks CLYM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow CLYM insider buys?
Create a free InsiderAlpha account and press Watch on this page to add CLYM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Breanna Maurine Celebi view on EDGAR
- - Aoife Brennan view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Andrew David Levin view on EDGAR
- - Kimberlee C. Drapkin view on EDGAR
- - Douglas E. Williams view on EDGAR
- - Alexander Cumbo view on EDGAR
- - Stephen Basil Thomas view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where CLYM's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track CLYM insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
